GLP-1 Dosing Schedule Guidance in Rochester: A Complete Titration Guide From Vital Health Medical Care

Starting a GLP-1 medication is one of the most consequential decisions a person can make in the treatment of obesity and how that medication is dosed over the following months has an enormous impact on both how well it works and how comfortable the journey feels. Too fast, and side effects can become overwhelming enough to derail treatment entirely. Too slow, and patients may spend months at doses that produce minimal results. Getting the titration schedule right is one of the single most important clinical skills in obesity medicine.

At Vital Health Medical Care, located at 10 Office Parkway, Suite 100 in Pittsford, NY, Dr. Sanin Syed brings dual board certifications from the American Board of Obesity Medicine and the American Board of Internal Medicine plus more than 20 years of clinical experience to the personalized dosing decisions that shape every Rochester patient’s outcome. Rather than applying a rigid, one-size-fits-all protocol, Dr. Syed calibrates each patient’s escalation schedule to their individual tolerance, clinical response, weight loss progress, and body composition data.

This comprehensive guide explains exactly how GLP-1 dosing works the FDA-approved titration schedules for each major medication, why gradual escalation matters, when to hold a dose versus advance, what to do about missed doses, and how Rochester patients at Vital Health Medical Care receive individualized dosing schedule guidance at every stage of their treatment.

⚠️  Medical Disclaimer: This article is for educational purposes only and does not constitute individualized medical advice. Dosing schedules must be determined by a qualified prescribing physician based on your specific health profile, medical history, and clinical response. Never adjust, skip, or change your GLP-1 dose without direct guidance from your prescriber. Contact Vital Health Medical Care at 585-662-5786 to discuss your personal treatment plan.

Why Gradual Dose Escalation Is Essential With GLP-1 Medications

Every FDA-approved GLP-1 receptor agonist for weight management follows a structured, stepwise titration schedule. This is not an arbitrary regulatory formality it is a clinically essential safety design rooted in how these medications interact with the digestive system.

Both semaglutide and tirzepatide work in part by slowing gastric emptying the rate at which food moves from the stomach into the small intestine. This slowing is precisely what produces prolonged satiety and reduced appetite. But it also means the digestive system must adapt to a fundamentally different pace of food processing. When a patient jumps too quickly to a high dose, that adaptation cannot keep up, and the result is severe nausea, vomiting, and diarrhea sometimes severe enough to cause dehydration requiring emergency care.

Gradual titration solves this problem elegantly. By starting at a low, sub-therapeutic dose and increasing incrementally every four weeks, the body is given adequate time to adapt at each level before the next increase. The result is dramatically better tolerability, higher treatment persistence, and ultimately better weight loss outcomes because patients who can tolerate their medication are patients who stay on it long enough to see meaningful results.

The Clinical Consequence of Poor Titration Management

Real-world research consistently shows that treatment persistence staying on GLP-1 therapy without interruption is one of the strongest predictors of weight loss success. Patients who discontinue early due to intolerable side effects never reach the therapeutic doses where the most significant weight reduction occurs. Conversely, patients who receive thoughtful, individualized titration management under expert supervision are far more likely to reach and sustain their maintenance dose. This is precisely the value that specialist-level dosing schedule guidance provides for Rochester patients at Vital Health Medical Care.

Wegovy (Semaglutide) Dosing Schedule: The FDA-Approved Titration Path

Wegovy is the higher-dose semaglutide formulation FDA-approved specifically for chronic weight management. It follows a five-step titration schedule reaching a standard maintenance dose of 2.4 mg once weekly. Each step lasts four weeks, and the complete titration to maintenance takes 16 weeks.

Standard Wegovy Titration Schedule

• Weeks 1–4: 0.25 mg once weekly Starter dose. This is not a therapeutic weight loss dose; its purpose is to allow the body to begin adapting to semaglutide with minimal side effects. Some appetite reduction may be noticed, but significant weight loss is not expected yet.
• Weeks 5–8: 0.5 mg once weekly First escalation. Appetite suppression typically becomes more noticeable. Mild GI symptoms may recur briefly after the increase.
• Weeks 9–12: 1.0 mg once weekly Second escalation. Most patients report meaningful appetite suppression and begin seeing consistent weight loss at this level.
• Weeks 13–16: 1.7 mg once weekly Third escalation. Approaching therapeutic maintenance levels. Weight loss typically accelerates.
• Week 17 onward: 2.4 mg once weekly Standard maintenance dose. This is the dose at which the STEP clinical trials demonstrated average weight reductions of approximately 15–17% of total body weight over 68 weeks.

Wegovy HD (7.2 mg): The Newer High-Dose Option

In 2025, the FDA approved a higher-dose formulation of Wegovy at 7.2 mg once weekly, following the STEP UP trial published in The Lancet Diabetes & Endocrinology. That trial demonstrated average weight loss of approximately 19–21% at the 7.2 mg dose meaningfully greater than the 16% seen at the standard 2.4 mg dose in the same study.

The titration path to 7.2 mg is longer and more gradual, requiring approximately 28 weeks through seven escalation steps. Importantly, the higher dose carries a distinct dose-dependent side effect: dysesthesia, an unusual tingling or numbness sensation, which occurred in approximately 18.9% of patients at 7.2 mg compared to 4.9% at 2.4 mg. For this reason, Wegovy HD is generally reserved for patients who tolerate the 2.4 mg maintenance dose well but seek additional weight reduction. Dr. Syed evaluates each Rochester patient individually to determine whether escalation beyond 2.4 mg is clinically appropriate and beneficial.

Ozempic (Semaglutide for Type 2 Diabetes)

Ozempic contains the same active ingredient as Wegovy but is FDA-approved for type 2 diabetes management rather than weight loss. Its titration follows the same early path 0.25 mg for four weeks, then 0.5 mg, then 1.0 mg but its maximum approved dose is 2.0 mg weekly, reached from approximately week 13. For patients whose primary treatment goal is weight management, Wegovy or Zepbound are typically the more clinically and administratively appropriate prescriptions, and Dr. Syed guides each patient toward the formulation best matched to their goals and insurance coverage.

Zepbound (Tirzepatide) Dosing Schedule: Six Doses, Flexible Maintenance

Zepbound is the tirzepatide formulation FDA-approved for chronic weight management and, more recently, for moderate-to-severe obstructive sleep apnea in adults with obesity. As a dual GLP-1 and GIP receptor agonist, tirzepatide has produced the most powerful weight loss results of any FDA-approved medication to date with the SURMOUNT-5 head-to-head trial showing 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks.

Zepbound is available in six FDA-approved doses, each delivered as a single-dose auto-injector pen. The titration schedule increases every four weeks:

• Weeks 1–4: 2.5 mg once weekly Starting dose. Designed to allow initial adaptation; not intended as a maintenance dose.
• Weeks 5–8: 5 mg once weekly First escalation. 5 mg is one of the three studied maintenance doses with published efficacy data some patients achieve their goals here and remain at this level long-term.
• Weeks 9–12: 7.5 mg once weekly Intermediate titration step.
• Weeks 13–16: 10 mg once weekly Second studied maintenance dose. Many patients reach their goal weight at 10 mg without needing further escalation.
• Weeks 17–20: 12.5 mg once weekly Intermediate titration step.
• Week 21 onward: 15 mg once weekly Maximum FDA-approved dose and the third studied maintenance level. No higher doses are FDA-approved for Zepbound.

Zepbound Offers Meaningful Dosing Flexibility

One of the most clinically valuable features of Zepbound’s dosing structure is that escalation to the maximum dose is not required. The FDA-approved labeling explicitly permits patients to remain at any dose where they are achieving satisfactory results with acceptable tolerability. A patient losing 1–2 pounds per week consistently at 7.5 mg has no clinical reason to escalate to 15 mg higher doses generally mean more pronounced side effects without necessarily producing proportionally better outcomes for that individual.

A 2024 real-world analysis of Zepbound prescribing patterns found that a substantial proportion of patients achieve their treatment goals without ever reaching the maximum dose. At Vital Health Medical Care, Dr. Syed uses each patient’s monthly body composition data measuring fat mass, lean muscle mass, and metabolic rate alongside weight trend data to make evidence-based decisions about whether to escalate, hold, or in some cases reduce the dose.

Mounjaro (Tirzepatide for Type 2 Diabetes)

Mounjaro contains the identical active ingredient and follows the identical titration schedule as Zepbound 2.5 mg through 15 mg in 2.5 mg increments every four weeks. The only difference is the FDA-approved indication: Mounjaro is approved for type 2 diabetes management, while Zepbound is approved for chronic weight management. For weight loss patients, Zepbound is typically the appropriate prescription and is more likely to be covered by insurance for that indication.

When to Escalate, When to Hold: Clinical Decision-Making at Vital Health Medical Care

The FDA-approved titration schedules represent standardized frameworks not rigid mandates. In expert clinical practice, dose escalation decisions are individualized based on several key factors that Dr. Syed evaluates at every follow-up visit.

Reasons to Escalate to the Next Dose

• Weight loss has plateaued for three or more consecutive weeks at the current dose
• Side effects from the current dose are minimal or have fully resolved
• Appetite suppression has diminished noticeably from earlier in treatment
• Body composition data shows the patient is losing fat effectively and preserving lean mass
• The patient remains meaningfully above their target weight and clinical goals

Reasons to Hold at the Current Dose

• Steady, consistent weight loss of approximately 1–2 pounds per week is occurring
• Gastrointestinal side effects from the most recent escalation have not fully resolved
• The patient reports appetite suppression that is already strong and satisfactory
• Body composition scans indicate excessive lean mass loss, warranting nutritional adjustment before further escalation
• The patient is approaching their goal weight and a maintenance strategy is appropriate

Reasons to Slow Down or Step Back

• Severe or persistent nausea, vomiting, or diarrhea following an escalation
• Inability to maintain adequate hydration or nutrition
• Signs of excessive rapid weight loss that risks disproportionate muscle loss
• Development of any concerning symptoms requiring clinical evaluation

At Vital Health Medical Care, these decisions are never made in isolation from the broader clinical picture. Monthly medical-grade body composition scans using bioelectrical impedance analysis (BIA) or dual-energy X-ray absorptiometry (DXA) technology give Dr. Syed objective data on fat loss versus lean mass preservation information that a scale simply cannot provide. This data directly informs whether escalation is appropriate, or whether nutritional and exercise adjustments should come first.

Practical Administration: Injection Timing, Sites, and Missed Doses

Choosing Your Injection Day

All GLP-1 medications for weight management are administered once weekly as a subcutaneous injection. Patients should select a consistent day of the week and administer their injection on that same day each week, with seven days between injections. Many patients in Rochester find it helpful to choose a day that allows them to be at home and relatively low-key for the following 24–48 hours when GI side effects, if any, tend to be most noticeable. A Friday or Saturday injection, for example, allows any adjustment symptoms to occur over the weekend rather than during a demanding work week.

The medication can be taken at any time of day, with or without food, offering meaningful flexibility for patients balancing busy Rochester-area work and family schedules.

Injection Sites and Rotation

GLP-1 medications are injected subcutaneously into the abdomen, thigh, or upper arm. Site rotation is important to prevent skin irritation, bruising, lipohypertrophy (fatty lumps), and localized reactions.

• Rotate injection sites with every dose never inject into the same exact spot consecutively
• If using the abdomen, stay at least two inches away from the navel
• Avoid injecting into areas with active skin conditions, bruising, scarring, or recent injection sites
• Allow the pen to reach room temperature for 15–30 minutes before injecting cold medication straight from the refrigerator can cause more stinging
• Pinch a small fold of skin to ensure the needle enters subcutaneous fat rather than muscle
• Apply gentle pressure after injecting without rubbing the site

Missed Dose Guidance

Missed doses happen and the correct response depends on how much time has elapsed. For semaglutide (Wegovy/Ozempic), which has a longer half-life, if the missed dose is remembered within five days of the scheduled date, it should be taken as soon as possible and the regular weekly schedule resumed. If more than five days have passed, the missed dose should be skipped entirely and the next dose taken on the regularly scheduled day.

For tirzepatide (Zepbound/Mounjaro), which has a shorter half-life of approximately five days, a missed dose can be taken within four days of the scheduled date. Beyond four days, the missed dose should be skipped and the regular schedule resumed. Two doses should never be taken within three days of one another.

Patients who miss multiple consecutive doses particularly two or more weeks should contact Vital Health Medical Care before resuming, as re-titration from a lower dose may be clinically necessary to avoid a resurgence of side effects.

Storage Requirements

• Store unused pens in the refrigerator between 36°F and 46°F
• Zepbound pens may be stored at room temperature (below 86°F) for up to 21 days if needed
• Keep pens in their original carton to protect from light
• Never freeze GLP-1 medications a frozen pen must be discarded
• Do not use a pen that has been dropped on a hard surface, as internal glass components may be damaged

Why Rochester Patients Choose Vital Health Medical Care for GLP-1 Dosing Management

Dosing schedule decisions are among the most clinically consequential aspects of GLP-1 therapy and they should be made by a physician with genuine specialist expertise in obesity pharmacology, not by an algorithm or a rushed telehealth encounter.

Specialist-Level Physician Oversight

Dr. Sanin Syed’s dual board certifications in obesity medicine and internal medicine represent the highest standard of qualification for prescribing and managing GLP-1 medications. Her expertise has been recognized on NPR’s Evan Dawson Show, at the Rochester Academy of Medicine, and through her role as Assistant Professor of Medicine at the University of Rochester Medical Center, where she teaches internal medicine residents and has been honored with the Best Teacher Award. Every dosing decision for every Rochester patient reflects that depth of clinical judgment.

Data-Driven Escalation Decisions

Vital Health Medical Care is one of the few medical weight loss centers in New York offering advanced body composition analysis as a foundational component of every program. Monthly BIA or DXA scans provide objective measurements of body fat percentage, visceral versus subcutaneous fat, lean muscle mass, bone density, hydration status, and basal metabolic rate. This data transforms dose escalation from guesswork into evidence-based clinical decision-making ensuring that weight loss is coming from fat rather than muscle, and that each escalation is justified by measurable progress.

Integrated Support Through Every Escalation

Each dose increase brings a brief window of renewed GI adjustment. Vital Health Medical Care surrounds every patient with the support needed to navigate these transitions comfortably: registered dietitian guidance on meals that minimize GI symptoms, culinary medicine classes teaching practical preparation of tolerable and nutritious foods, individualized exercise planning that preserves lean muscle mass, behavioral and lifestyle coaching to maintain motivation through challenging weeks, and direct clinical access to Dr. Syed’s team for any concerns that arise.

Insurance Navigation Throughout Treatment

Dose escalations sometimes require updated prior authorizations, and pen strength changes can create pharmacy or insurance friction. Vital Health Medical Care’s administrative team proactively manages insurance verification, prior authorization submissions, appeals, and savings program enrollment throughout each patient’s entire treatment course so that administrative barriers never interrupt a carefully calibrated titration schedule. No physician referral is required to get started.

Serving Rochester and the Greater Monroe County Community

Vital Health Medical Care was founded in 2022 with a clear mission: to bring the highest standard of medically supervised obesity medicine to Rochester, New York. Located at 10 Office Parkway, Suite 100 in Pittsford conveniently across from the Jefferson and Clover Road YMCA the clinic serves patients throughout the greater Rochester metro area, including Brighton, Fairport, Victor, Penfield, Greece, Webster, Irondequoit, Henrietta, and surrounding Monroe County communities.

Dr. Syed’s commitment to the Rochester community extends well beyond her clinical practice. Through her appearances on NPR’s Evan Dawson Show, her invited lectures at the Rochester Academy of Medicine, and her ongoing academic work at the University of Rochester Medical Center, she has invested substantially in public education around obesity as a chronic medical condition helping Rochester-area residents understand both the science and the practical realities of modern obesity treatment.

Frequently Asked Questions: GLP-1 Dosing Schedule Guidance in Rochester, NY

Q1: How long does it take to reach the full dose of Wegovy or Zepbound?

For Wegovy (semaglutide), the standard titration to the 2.4 mg maintenance dose takes 16 weeks through five steps: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with four weeks at each level. The newer Wegovy HD 7.2 mg dose requires approximately 28 weeks through seven steps. For Zepbound (tirzepatide), reaching the maximum 15 mg dose takes approximately 20–21 weeks through six steps: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, again with four weeks at each level. Importantly, not every patient needs to reach the maximum dose many achieve their goals at intermediate maintenance levels. At Vital Health Medical Care, Dr. Syed personalizes each patient’s escalation pace based on tolerance, weight loss progress, and body composition data.

Q2: Can I stay on a lower GLP-1 dose if it is working well?

Yes and in many cases this is the clinically optimal choice. FDA-approved labeling for Zepbound explicitly permits patients to remain at any dose where they are achieving satisfactory results, and 5 mg, 10 mg, and 15 mg are all recognized maintenance doses with published efficacy data. For Wegovy, some patients hold at 1.7 mg if 2.4 mg is not well tolerated. If you are losing approximately 1–2 pounds per week consistently and tolerating your current dose well, there is generally no clinical reason to escalate further. Higher doses typically mean more pronounced side effects without necessarily proportionally better results for that individual. Dr. Syed makes this determination collaboratively with each Rochester patient using objective progress data.

Q3: What should I do if I miss a GLP-1 dose?

For semaglutide (Wegovy or Ozempic): if you remember within five days of your scheduled dose, take it as soon as possible and resume your normal weekly schedule. If more than five days have passed, skip the missed dose entirely and take your next dose on the regularly scheduled day. For tirzepatide (Zepbound or Mounjaro): if you remember within four days, take the missed dose and resume your schedule. Beyond four days, skip it. Never take two doses within three days of one another. If you have missed two or more consecutive weekly doses, contact Vital Health Medical Care at 585-662-5786 before resuming re-titrating from a lower dose may be necessary to avoid a return of significant side effects.

Q4: Why do side effects come back every time my dose increases?

This is entirely expected and reflects how these medications work. Each dose increase intensifies the medication’s effect on gastric emptying the slowing of food movement from the stomach into the intestine. Your digestive system needs time to adapt to each new level, and during that adaptation period, nausea, bloating, or bowel changes commonly recur briefly. These symptoms typically peak in the first few days after an escalation and diminish substantially over the following one to two weeks. If side effects from an escalation do not resolve within about two weeks, or if they are severe enough to prevent adequate eating and hydration, Dr. Syed may recommend holding at the previous dose longer before advancing, or slowing the escalation pace.

Q5: Should I inject my GLP-1 medication on a specific day or time?

You should choose one consistent day of the week and administer your injection on that same day every week, maintaining seven days between doses. The time of day does not matter clinically GLP-1 medications for weight management can be taken with or without food at any hour. Many Rochester patients find it practical to choose a day when they can be at home and relatively low-key for the following 24–48 hours, since any GI adjustment symptoms tend to be most noticeable in that window. A Friday or Saturday injection, for instance, lets any early symptoms occur over the weekend. If you need to change your injection day, this can be done as long as at least 72 hours (three days) have passed since your last dose discuss the transition with Dr. Syed’s team first.

Q6: Is the dosing schedule for Mounjaro the same as Zepbound?

Yes. Mounjaro and Zepbound both contain tirzepatide as the identical active ingredient and follow the exact same titration schedule: 2.5 mg weekly for four weeks, then increasing by 2.5 mg increments every four weeks through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg as the maximum FDA-approved dose. The only difference between the two brands is the FDA-approved indication Mounjaro is approved for type 2 diabetes management, while Zepbound is approved for chronic weight management and obstructive sleep apnea. For patients whose primary goal is weight loss, Zepbound is typically the appropriate prescription and is more likely to receive insurance coverage for that indication.

Q7: Can I adjust my own GLP-1 dose based on how I feel?

No. Self-adjusting GLP-1 doses whether increasing, decreasing, or skipping carries meaningful clinical risk and should never be done without direct guidance from your prescribing physician. Increasing your dose independently can cause severe gastrointestinal side effects including dehydration requiring emergency care. Decreasing or skipping doses can undermine your weight loss progress and, if you later resume at your previous dose, can trigger a return of significant side effects. If your current dose is causing problems or does not seem to be working, contact Dr. Syed at Vital Health Medical Care to discuss a clinically appropriate adjustment. The clinic can be reached at 585-662-5786.

Q8: How does Vital Health Medical Care personalize dosing decisions for Rochester patients?

Vital Health Medical Care combines specialist-level physician expertise with objective clinical data to individualize every dosing decision. Dr. Syed dual board-certified in obesity medicine and internal medicine with over 20 years of experience evaluates each patient’s weight trend, side effect profile, and clinical goals at every follow-up. Critically, monthly medical-grade body composition scans using BIA or DXA technology provide objective measurements of fat mass, lean muscle mass, and metabolic rate. This data reveals whether weight loss is coming from fat or muscle, whether nutritional adjustments should precede a dose increase, and whether escalation is genuinely warranted. Combined with registered dietitian support, exercise planning, behavioral coaching, and full insurance navigation, this integrated approach ensures each Rochester patient’s titration schedule is optimized for both comfort and results.

Get Expert GLP-1 Dosing Guidance in Rochester at Vital Health Medical Care

The difference between a GLP-1 treatment course that succeeds and one that stalls often comes down to how thoughtfully the dosing schedule is managed. Escalate too aggressively and side effects derail treatment. Hold too conservatively and patients spend months below therapeutic levels. Getting it right requires specialist clinical judgment, objective progress data, and a support system that helps patients through each transition.

At Vital Health Medical Care, Dr. Sanin Syed and her team deliver exactly that. From your initial consultation and baseline body composition scan through every escalation decision and maintenance adjustment, your dosing schedule is calibrated to your body, your tolerance, your goals, and your measurable results not to a generic protocol.

Whether you are just beginning GLP-1 therapy, struggling with side effects on your current dose, or seeking expert guidance on whether to escalate, Vital Health Medical Care offers Rochester’s most comprehensive and clinically rigorous approach to GLP-1 dosing management.

⚠️  Reminder: The dosing schedules described in this article reflect FDA-approved labeling and general clinical practice. Your individual schedule may differ based on your medical history, tolerance, and clinical response. Never adjust your dose without consulting your prescribing physician.

Meet Dr. Sanin Syed – Leading Medical Weight Loss Specialist in Rochester, NY

Dr. Sanin Syed, founder and CEO of Vital Health Medical Care, is a board-certified obesity and internal medicine specialist. With over two decades of experience, Dr. Syed is dedicated to helping her patients achieve lasting weight loss and a healthier lifestyle.

• Recognized Expertise: Dr. Syed’s knowledge has been featured on NPR’s Evan Dawson Show and in the Rochester Academy of Medicine.
• Commitment to Patient Health: She focuses on building sustainable health habits and lifestyle changes that support long-term success.

Our clinic, located at 10 Office Parkway, Suite 100, Pittsford, NY, provides a welcoming and professional setting for patients who are ready to make positive changes.

Why Choose Vital Health Medical Care?

Experienced Weight Loss Doctor

Dr. Sanin Syed is one of the leading weight loss doctors in New York, with over 20 years of experience in medicine and obesity management. She holds dual board certifications from the American Board of Obesity Medicine and the American Board of Internal Medicine, ensuring you receive the highest standard of care.

Personalized Care

At Vital Health Medical Care, we believe in a personalized approach to weight loss. Our programs are tailored to meet your unique needs, ensuring you receive the best possible care and support on your weight loss journey.

Comprehensive Support

We provide ongoing support throughout your weight loss journey, including regular monitoring and adjustments to your plan as needed. Our comprehensive approach ensures you have the resources and guidance necessary to achieve your weight loss goals.

Insurance Acceptance

We understand that managing healthcare costs is important. That’s why we accept a wide range of insurance plans to make our weight loss treatments accessible and affordable for everyone.

Nutritional Counseling

Our qualified nutritionists create personalized diet plans that fit your lifestyle and dietary preferences. We provide expert guidance on making healthy food choices that support your weight loss goals.

Physician Consultation

Our experienced physicians, led by Dr. Syed, will work with you to find the best medication and treatment plan for your needs. We utilize FDA-approved medications such as Wegovy and Zepbound to support your weight loss efforts.

Health Coaching

Our health coaches provide ongoing support and motivation, helping you stay on track with your weight loss goals. They offer practical advice and encouragement to help you overcome challenges and achieve lasting success.

Culinary Medicine

Learn how to prepare healthy, delicious meals that support your weight loss journey with guidance from our culinary medicine experts. We offer cooking classes and workshops to help you develop the skills needed to maintain a healthy diet.

Meal Replacement

We offer meal replacement options that are nutritious and convenient, helping you manage your calorie intake effectively. Our meal replacements are designed to support your weight loss goals while ensuring you receive essential nutrients.

Individualized Exercise Plan

Our fitness experts develop personalized exercise plans tailored to your fitness level and goals. We provide guidance on the best types of exercise for weight loss and overall health, ensuring you achieve optimal results.

Comprehensive Weight Loss Treatment in Rochester, New York

Vital Health Medical Care offers evidence-based weight loss treatments designed to help you succeed. We take a holistic approach, integrating medication, diet, exercise, and behavioral changes to ensure long-term success. Contact us today to schedule a consultation and start your journey.